Mercado mundial de marcapasos cardíacos: tendencias de la industria y pronóstico hasta 2031

Análisis y tamaño del mercado de marcapasos cardíacos

Según los Centros para el Control y la Prevención de Enfermedades (CDC), más de 600.000 personas sufren muerte súbita cardíaca cada año, y la mitad de ellas fallecen durante el episodio cardíaco inicial, a menudo sin signos previos de enfermedad coronaria. A medida que aumenta la edad, aumenta la prevalencia de arritmias auriculares y ventriculares. Se prevé que el impacto económico de estas afecciones supere los 1.044 billones de dólares en 2030, lo que subraya el papel esencial de los dispositivos de estimulación cardíaca en el manejo de estos problemas de salud. Los marcapasos cardíacos desempeñan un papel crucial en el manejo de las arritmias y la bradicardia, afecciones prevalentes entre los grupos demográficos de mayor edad. Se prevé que el mercado siga creciendo a medida que los avances tecnológicos aborden las necesidades clínicas y los cambios demográficos contribuyan a aumentar la demanda de terapias cardiovasculares a nivel mundial.         

El tamaño del mercado mundial de marcapasos cardíacos se valoró en USD 5.06 mil millones en 2023 y se proyecta que alcance los USD 7.47 mil millones para 2031, con una CAGR del 4.99% durante el período de pronóstico de 2024 a 2031. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance del informe y segmentación del mercado       

Market Definition

Cardiac pacemakers are small, implantable medical devices that are designed to regulate the heart's rhythm by delivering electrical impulses to the heart muscle. They are used primarily to treat arrhythmias, irregular heartbeats, and conditions where the heart beats too slowly (bradycardia). Pacemakers consist of a pulse generator, which houses the battery and electronic circuits that generate electrical impulses and leads (wires) that deliver these impulses from the generator to specific locations in the heart.         

Cardiac Pacemakers Market Dynamics

Drivers

• Increasing Prevalence of Cardiovascular Diseases      

The rising incidence of cardiovascular disorders, such as arrhythmias and heart blockages, is a significant driver for the cardiac pacemakers market. As global populations face increasing rates of lifestyle-related diseases and aging demographics, the prevalence of heart rhythm abnormalities is rising. Pacemakers play a crucial role in managing these conditions by regulating the heart's electrical activity, thereby reducing symptoms and improving the quality of life for patients. This growing patient pool in need of cardiac intervention fuels demand for pacemakers, driving innovation and market expansion across regions.                                

• Rising Aging Population    

Demographic shifts towards an aging population globally contribute to a higher demand for cardiac pacemakers. Older adults are more susceptible to heart rhythm abnormalities due to age-related changes in cardiac function. For instance, according to information from the World Population Prospects: Highlights 2020, the global population aged over 65 is projected to reach approximately 1.5 billion by 2050, marking a significant increase from 727 million in 2020. As life expectancy increases and healthcare improves, the number of elderly individuals requiring pacemaker implantation to manage conditions such as bradycardia and atrial fibrillation continues to grow. This demographic trend underscores the importance of advanced cardiac care and the role of pacemakers in enhancing longevity and quality of life among older adults, thereby driving market growth and technological advancements in pacemaker technology.

Opportunities

• Technological Innovations in Pacemaker Technology     

Continuous innovations in pacemaker technology, such as miniaturization, longer battery life, and advanced programming capabilities, significantly enhance device efficacy and patient outcomes. Miniaturization allows for smaller and less invasive implantation procedures, reducing patient discomfort and recovery times. Longer battery life ensures extended device longevity, minimizing the need for frequent replacements and improving patient convenience. Advanced programming capabilities enable personalized treatment approaches tailored to individual patient needs, optimizing therapeutic outcomes and reducing complications. These technological advancements not only enhance the performance and reliability of pacemakers but also drive adoption rates globally by meeting the evolving healthcare needs of patients with cardiac rhythm disorders.     

• Expansion of Healthcare Infrastructure  

Improvements in healthcare access and infrastructure development in emerging markets are expanding the patient pool eligible for cardiac treatments, including pacemaker implantation. As economies grow and healthcare systems modernize, more patients gain access to specialized cardiac care services and advanced medical technologies. This expansion of healthcare infrastructure supports increased diagnosis and treatment of cardiovascular diseases, driving demand for pacemakers and other cardiac devices. Moreover, initiatives aimed at reducing healthcare disparities and improving access to affordable medical treatments further bolster market growth opportunities in emerging regions.

Restraints/Challenges

• High Cost of Pacemaker Devices   

The cardiac pacemaker price and the cost of associated surgical procedures can pose significant challenges for patients and healthcare systems, particularly in developing regions with limited financial resources. The high upfront costs often deter patients from seeking timely treatment, leading to delayed interventions and potentially worsening health outcomes. Additionally, healthcare providers face financial constraints in acquiring expensive medical devices and ensuring adequate reimbursement for procedures.        

• Stringent Regulatory Requirements         

Strict regulatory approval processes and compliance standards delay market entry and product commercialization, posing challenges for cardiac pacemaker manufacturers. Regulatory agencies enforce rigorous safety and efficacy criteria to ensure patient safety and device reliability, which necessitates extensive clinical trials and documentation. The lengthy approval timelines and stringent requirements increase development costs and time-to-market for new pacemaker technologies. Manufacturers must navigate complex regulatory landscapes across different regions, adhering to varying standards and requirements, which can hinder innovation and market competitiveness.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In June 2021, Medtronic introduced the Micra AV, a compact and self-contained pacemaker designed to provide advanced pacing technology to patients with atrioventricular (AV) block. This device offers a minimally invasive implantation procedure, emphasizing its innovative approach to cardiac care                
• In January 2021, Boston Scientific Corporation revealed its intention to acquire Preventice Solutions, a developer specializing in remote cardiac monitoring

Cardiac Pacemakers Market Scope

The market is segmented on the basis of type, technology, application, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• MRI Compatible Pacemaker
• Conventional Pacemaker
• Implantable Pacemaker
• External Pacemaker

Technology

• Single-chamber Pacemaker
• Dual-chamber Pacemaker
• Biventricular/CRT Pacemaker

Application

• Arrhythmia
• Atrial Fibrillation
• Bradycardia
• Tachycardia
• Others

End-User

• Hospitals and Cardiac Centres
• Ambulatory Surgical Centres

Cardiac Pacemakers Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, type, technology, application, and end-user as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to rapid technological advancements and favorable regulatory environments. Innovations such as MRI-compatible pacemakers and Bluetooth-enabled pacemakers have significantly enhanced the functionality and convenience of these medical devices, leading to higher adoption rates across the region.  

Se espera que la región Asia-Pacífico sea testigo de un crecimiento significativo durante el período de pronóstico debido a las importantes inversiones en el sector de la atención de la salud. Países como Japón, India y China están a la vanguardia de este crecimiento, con importantes inversiones destinadas a mejorar la infraestructura de atención de la salud, mejorar el acceso de los pacientes a tecnologías médicas avanzadas y ampliar los servicios de atención de la salud.

La sección de países del informe también proporciona factores de impacto de mercado individuales y cambios en la regulación en el mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Puntos de datos como análisis de la cadena de valor aguas abajo y aguas arriba, tendencias técnicas y análisis de las cinco fuerzas de Porter, estudios de casos son algunos de los indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas globales y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales se consideran al proporcionar un análisis de pronóstico de los datos del país.

Crecimiento de la infraestructura de atención de salud Base instalada y penetración de nuevas tecnologías

El mercado también le ofrece un análisis detallado del mercado para cada país: crecimiento del gasto sanitario en equipos de capital, base instalada de diferentes tipos de productos para el mercado, impacto de la tecnología mediante curvas de línea de vida y cambios en los escenarios regulatorios de la atención sanitaria y su impacto en el mercado. Los datos están disponibles para el período histórico 2016-2021.

Análisis del panorama competitivo y de la cuota de mercado de los marcapasos cardíacos

El panorama competitivo del mercado proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y variedad de productos, y el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado.

Algunos de los principales actores que operan en el mercado son:

• OSYPKA MEDICAL (Alemania)
• Boston Scientific Corporation (Estados Unidos)
• Zoll Medical Corporation (Estados Unidos)
• Medtronic (Irlanda)
• BIOTRONIK SE & Co KG (Alemania)
• Corporación científica MicroPort (China)
• MEDICO SRL (Italia)
• Shree Pacetronix Ltd. (India)
• Abbott (Estados Unidos)
• OSCOR Inc (Estados Unidos)
• Tecnología médica Lepu (Beijing) Co., Ltd (China)

SKU-1391